Create the
Future of Health
Extrusion- and light-based bioprinters
Leverage a comprehensive portfolio of world-class light- and extrusion-based bioprinters to create more complex bioconstructs with added precision and multiple materials.
White paper: The Advent of Bioprinters
Advances in CELLINK’s portfolio have democratized bioprinting by making quality bioprinters accessible to a wider audience of researchers, who will create the future of bioprinted transplantable organs.
Customer spotlights
PATIENT-SPECIFIC TUMOR MODELS FOR INDIVIDUALIZED DRUG TESTING
Carcinotech CEO Ishani Malhotra on breast cancer awareness and leveraging the BIO X.
MASS-PRODUCED STEM CELLS
Ronawk’s T-blocks enable the production of adult stem cells in large quantities.
Award-winning designs
Browse the
complete portfolio
Trusted by
industry leaders
We are a BICO company
CELLINK is proud to be a part of BICO, the world’s leading bioconvergence company, which leverages the synergies of its premier companies in engineering, robotics, artificial intelligence, advanced genomics and bioprinting to create the future of health.
BICO envisions a future that ensures bioprinted organ transplants are obtainable, cultivated human tissues replace animal testing, every patient can get personalized medicine, drug development is faster and less expensive, easy-to-access diagnostics prevent pandemics.
